Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	0%	61.3	$
CMSC	-0.2%	22.065	$
NGG	1.52%	82.83	$
VOD	-1.74%	13.81	$
RELX	-0.19%	31.15	$
RYCEF	-0.89%	18	$
BTI	1.06%	61.39	$
RIO	-1.65%	94.03	$
BP	-3.88%	37.86	$
GSK	-1.92%	51.09	$
CMSD	0.27%	22.02	$
JRI	-0.48%	12.57	$
BCE	0.69%	23.2	$
BCC	7.55%	77.66	$
AZN	1.09%	183.02	$

Featured

Mothers search, men weep amid debris of Venezuela quakes

"Antonio, it's your mom, I'm right here," a mother's desperate cries bounced off the rubble of a 22-story building in Caracas that collapsed following two powerful earthquakes in Venezuela on Wednesday.

Venezuela declares state of emergency after powerful twin quakes

Venezuela's interim leader declared a state of emergency Wednesday as two massive earthquakes caused buildings in the capital to crumble and forced the closure of the country's main airport.

Last news

Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually, on Thursday, May 29, 2025.

Genflow Biosciences PLC Announces AGM Notice

LONDON, UNITED KINGDOM / ACCESS Newswire / May 22, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that it will hold its Annual General Meeting ("AGM") at 9am on Thursday 12 June 2025 at One Heddon Street, London, W1B 4BD.

The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 22, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration, will be participating in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5th, 2025, at 2:00 pm ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.

Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

GENEVA, SWITZERLAND / ACCESS Newswire / May 22, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to RLF-TD011 for the treatment of epidermolysis bullosa (EB), a rare genetic skin disorder characterized by fragile skin and chronic wounds. The FDA had previously granted Orphan Drug Designation to RLF-TD011 for the same indication.

Consumer groups want airlines to pay for baggage fees 'distress'

Sixteen European consumer groups on Wednesday called on the European Union to take action against seven low-cost airlines over their baggage fees.

Irish rapper charged over Hezbollah flag at London concert: police

A member of Irish rap group Kneecap has been charged with a terror offence for allegedly displaying a Hezbollah flag at a London concert, police said on Wednesday.

Vietnam jails 23 people over rare earths exploitation

A Vietnamese court on Wednesday jailed 23 officials and business people over the illegal exploitation and export of rare earths.

Macron party backs banning hijab in public spaces for under 15s

French President Emmanuel Macron's political party wants to ban minors under 15 from wearing the Muslim headscarf in public, with the government set to review a report Wednesday on the spread of "political Islamism" in France.

Cyberattack costs UK retailer Marks & Spencer £300 mn

British clothes-to-food retailer Marks and Spencer on Wednesday said a cyberattack disrupting its online service is set to last through to July and hit group profit by around £300 million ($404 million).

Flood victims stranded on roofs as downpours lash eastern Australia

Fast-moving floodwaters rose Wednesday in eastern Australia, inundating homes and leaving residents stranded on their roofs overnight, as authorities warned more rain was expected in coming days.

High-flying young electricians wire UK energy switch

Perched 45 metres (148 feet) high, young apprentice electricians replace a connection atop a pylon. In the UK, National Grid recruitment is at full power as its electricity network adapts for renewables.

Labor Smart, Inc. Shareholder Letter - Q1 2025 From the Office of the CEO

JACKSON, WY / ACCESS Newswire / May 21, 2025 / Dear Shareholders,

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended March 31, 2025.

Kidpik and Nina Footwear Announce Closing of Business Combination

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Kidpik Corp. (OTC PINK:PIKM) ("Kidpik"), a kids' online clothing subscription-based e-commerce company, and Nina Footwear Corp., a private company operating a brand specializing in women's and kids' dress shoes and accessories for special occasions ("Nina Footwear"), today announced that they have entered into and closed the transactions contemplated by a merger agreement.

AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street

Strategic media partnership will amplify AINOS's brand and innovation story across major financial networks and digital platforms

Pet Diets Are Quietly Contributing to Climate Change - but There's a Simple Fix

A new study has revealed that conventional meat-based pet food carries a largely unrecognized environmental cost - contributing significantly to land use, greenhouse gas (GHG) emissions, and climate breakdown. The review, just published, found that pet food production is closely tied to the livestock industry, which is responsible for at least one-fifth of annual global GHG emissions.

Nutrition Business Journal Report Provides Unparalleled Market Intelligence on $69.3 Billion Supplement Industry

BOULDER, CO / ACCESS Newswire / May 21, 2025 / Nutrition Business Journal (NBJ), the leading business intelligence and market research resource in the nutrition and supplements industry, today announces the release of the 2025 Supplement Business Report, offering the most detailed analysis of the dietary supplement market to date, a market valued at $69.3 billion in 2024 and estimated to reach almost $87 billion in 2028.

27th Annual Food Safety Summit Draws More Than 4,700 Industry Professionals in Person and Virtually

2026 Summit Set for May 11-14 in Rosemont, IL

Fall 2025 Makeup Trends, According to the Makeup Artist Who's Seen It All

By the time a trend hits TikTok, the pros have already moved on. That's why we asked international makeup artist and NYFW insider Yuliya Morska to break down what's actually next in beauty-and what we should leave behind with our summer gloss.

New Report Reveals Shifting Dynamics in U.S. Fashion Consumer Behavior

Industry-leading market analysis from the Informa Markets’ fashion portfolio provides essential insights for fashion industry decision-makers

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") announced today that warrant exchanges and exercises over the last four trading days have generated $3.1 million in cash. The proceeds will fund working-capital needs and advance the Company's peptide-based drug candidates for stress-related and central-nervous-system disorders.

M2i Global, Inc. Appoints Former White House CISO and Senior Trump Administration Official Camilo Sandoval as Senior Advisor

Brings Executive Insight and Trusted Relationships Across Business, Technology, and Government-Helping Shape AI and Cybersecurity Policy To Drive Government Modernization and Enhance Supply Chain Security.

Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND

Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1's upcoming IND submission for a rare disease indication

Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's In Response To Additional Shareholder Questions

AUSTIN, TEXAS / ACCESS Newswire / May 21, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it has updated its investor FAQ's on its investor website in response to shareholder questions around its AGM date and other corporate actions.

Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and sale of 246,306 shares of common stock at a purchase price of $6.09 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company agreed to issue to investors unregistered warrants to purchase up to 492,612 shares of common stock at an exercise price of $5.84 per share that will be immediately exercisable upon issuance and will expire on the earlier of (i) 24 months from the date of issuance, (ii) the consummation of a fundamental transaction and (iii) the consummation of a liquidation event. The closing of the offering is expected to occur on or about May 22, 2025, subject to the satisfaction of customary closing conditions.

Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000

Regenerative Medical Technologies Group, Inc. $RMTG, a regenerative medicine company, is pleased to announce that sales for its first quarter of 2025 surpassed $1.35M and achieved operational profits of $134,000 for the quarter.

Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025

NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York, NY. The Company will also participate in one-on-one meetings.

Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA) for mRNA-1083, its flu/COVID combination vaccine candidate for adults aged 50 years and older. The Company plans to resubmit the BLA later this year, after vaccine efficacy data from the ongoing Phase 3 trial of its investigational seasonal influenza vaccine, mRNA-1010, are available. Moderna continues to expect interim data from the mRNA-1010 trial to be available this summer.

Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution

The TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab

PPN Expands Influence in Pharmacy Media with New Hosting Platform and June Podcast Lineup

Pharmacy Podcast Network Unveils New Host Membership & Analytics Platform, Announces Four New Podcast Launches for June

ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women’s Health

Round led by Jeito Capital, co-led by AXA IM Alts and M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures

Arizona Tribune - Boulevard (English)